Brandywine Global Investment Management LLC Reduces Stock Position in Cardinal Health, Inc. $CAH

Brandywine Global Investment Management LLC cut its stake in Cardinal Health, Inc. (NYSE:CAH) by 2.5% in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 142,534 shares of the company’s stock after selling 3,639 shares during the quarter. Brandywine Global Investment Management LLC owned about 0.06% of Cardinal Health worth $23,946,000 at the end of the most recent quarter.

A number of other institutional investors have also added to or reduced their stakes in the stock. Wellington Management Group LLP increased its position in shares of Cardinal Health by 1,666.7% during the first quarter. Wellington Management Group LLP now owns 2,384,192 shares of the company’s stock valued at $328,470,000 after buying an additional 2,249,241 shares during the period. JPMorgan Chase & Co. boosted its position in shares of Cardinal Health by 40.0% in the first quarter. JPMorgan Chase & Co. now owns 4,175,992 shares of the company’s stock valued at $575,327,000 after acquiring an additional 1,193,983 shares during the period. Zurich Insurance Group Ltd FI grew its stake in Cardinal Health by 4,935.9% during the first quarter. Zurich Insurance Group Ltd FI now owns 946,750 shares of the company’s stock valued at $130,434,000 after acquiring an additional 927,950 shares in the last quarter. Acadian Asset Management LLC increased its holdings in Cardinal Health by 92.5% during the 2nd quarter. Acadian Asset Management LLC now owns 1,679,176 shares of the company’s stock worth $282,063,000 after acquiring an additional 807,063 shares during the period. Finally, Nuveen LLC purchased a new stake in Cardinal Health in the 1st quarter worth approximately $106,065,000. Hedge funds and other institutional investors own 87.17% of the company’s stock.

Cardinal Health Price Performance

Shares of Cardinal Health stock opened at $209.27 on Friday. Cardinal Health, Inc. has a one year low of $114.60 and a one year high of $210.32. The business’s 50 day simple moving average is $171.23 and its two-hundred day simple moving average is $161.11. The stock has a market capitalization of $49.72 billion, a P/E ratio of 32.45, a price-to-earnings-growth ratio of 1.39 and a beta of 0.72.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings results on Thursday, October 30th. The company reported $2.55 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.22 by $0.33. The business had revenue of $64.01 billion for the quarter, compared to analyst estimates of $59.41 billion. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The company’s revenue was up 22.4% on a year-over-year basis. During the same quarter last year, the firm earned $1.88 EPS. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. Sell-side analysts expect that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, January 15th. Investors of record on Friday, January 2nd will be given a dividend of $0.5107 per share. The ex-dividend date is Friday, January 2nd. This represents a $2.04 annualized dividend and a dividend yield of 1.0%. Cardinal Health’s payout ratio is currently 30.77%.

Analysts Set New Price Targets

Several research analysts have recently weighed in on the stock. UBS Group upped their price target on shares of Cardinal Health from $185.00 to $220.00 and gave the stock a “buy” rating in a report on Friday, October 31st. Wall Street Zen upgraded Cardinal Health from a “buy” rating to a “strong-buy” rating in a research report on Saturday, November 8th. Mizuho raised their price target on Cardinal Health from $170.00 to $210.00 and gave the company an “outperform” rating in a report on Monday, November 3rd. Argus lifted their price target on Cardinal Health from $189.00 to $211.00 and gave the company a “buy” rating in a research report on Tuesday, November 4th. Finally, Jefferies Financial Group set a $220.00 price objective on shares of Cardinal Health and gave the stock a “buy” rating in a research report on Monday, November 3rd. Twelve research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $206.57.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.